 |
|
 |
- December 1, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"Have the Guidelines Jumped Ahead of the Evidence?"Dr. Stephen Colagiuri (biography)
English - 2004-06-26 - 32 minutes
|
 | (34 slides) |
Summary :
In this presentation, Dr. Stephen Colagiuri examines how clinical practice guidelines are developed and asks “have the guidelines jumped ahead of the evidence” in diabetes.
Dr. Colagiuri discusses what our expectations of clinical practice guidelines are, the limitations of guidelines, and gives an overview of how guidelines are developed and what is involved in their preparation.
Dr. Colagiuri also discusses why we are prepared to accept certain levels of evidence in certain circumstances, but demand higher levels in others and gives examples of these.
The presentation concludes with a discussion of the results of the CARDS study.
Copyright © 2004 E-MedHosting.com Inc
Learning objectives :
After viewing this presentation, participants will be able to discuss:
- What is expected of Guidelines
- What are the limitations of Guidelines
- The general process by which guidelines are developed
- The CARDS study (Collaborative Atorvastatin Diabetes Study)
Bibliographic references :
Allen IE, Olkin I. Estimating time to conduct a meta-analysis from number of citations retrieved. Estimating time to conduct a meta-analysis from number of citations retrieved.
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004 Aug 21;364(9435):685-96.
Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003 Jun 28;326(7404):1423.
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
